Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
NCT Number: NCT01557465
The purpose of this study is to determine whether mechanical alternans (alternating strong and weak heart beats with a constant beat-to-beat interval), can be used to predict malignant ventricular arrhythmias, requiring defibrillation or appropriate ICD therapies, and to predict progression of heart failure and death.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Baltimore, Maryland, 21205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
appropriate ICD therapy due to fast ventricular tachycardia or ventricular fibrillation, or sudden cardiac death
Time frame: 5 years
Time frame: 5 years
Time frame: 5 years
either ICD shock or antitachycardia pacing due to ventricular arrhythmia
Time frame: 5 years
pump-failure death, or heart transplantation, or heart failure hospitalization, whichever came first
Johns Hopkins University
Other
Study of Mechanical Alternans for Prediction of Ventricular Tachyarrhythmias
Acronym: MAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01215253
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Tucson, Arizona, United States
View Trial DetailsNCT01999140
Cardiovascular Diseases, Complications; Device, Cardiac
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03531151
Cardiomyopathies, Cardiovascular Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01288560
Arterial Occlusive Diseases, Arteriosclerosis
Boston, Massachusetts, United States
View Trial Details